170 related articles for article (PubMed ID: 37117002)
21. PSA testing for men at average risk of prostate cancer.
Armstrong BK; Barry MJ; Frydenberg M; Gardiner RA; Haines I; Carter SM
Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765854
[TBL] [Abstract][Full Text] [Related]
22. Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study.
Kirkegaard P; Edwards A; Nielsen TLO; Ørntoft TF; Sørensen KD; Borre M; Bro F
BMC Fam Pract; 2018 Feb; 19(1):32. PubMed ID: 29454309
[TBL] [Abstract][Full Text] [Related]
23. The Impact of Receipt of Information on Prostate-Specific Antigen Testing on Screening with the Prostate-Specific Antigen Test.
McCormick ME; Haile ZT
J Cancer Educ; 2023 Aug; 38(4):1313-1321. PubMed ID: 36652189
[TBL] [Abstract][Full Text] [Related]
24. Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot study.
Guerra CE; Jacobs SE; Holmes JH; Shea JA
J Gen Intern Med; 2007 Jul; 22(7):901-7. PubMed ID: 17549576
[TBL] [Abstract][Full Text] [Related]
25. Prostate-Specimen Antigen (PSA) Screening and Shared Decision Making Among Deaf and Hearing Male Patients.
Kushalnagar P; Hill C; Carrizales S; Sadler GR
J Cancer Educ; 2020 Feb; 35(1):28-35. PubMed ID: 30353474
[TBL] [Abstract][Full Text] [Related]
26. Physician Attitudes and Self-reported Practices Toward Prostate Cancer Screening in Black and White Men.
Shungu N; Diaz VA; Perkins S; Kulshreshtha A
Fam Med; 2022 Jan; 54(1):30-37. PubMed ID: 35006597
[TBL] [Abstract][Full Text] [Related]
27. Seniority of primary care physicians is associated with a decrease in PSA ordering habits in the years surrounding the United States Preventative Services Task Force recommendation against PSA screening.
Hutchinson R; Singla N; Akhtar A; Haridas J; Bhat D; Roehrborn C; Lotan Y
Urol Oncol; 2018 Nov; 36(11):500.e21-500.e27. PubMed ID: 30241954
[TBL] [Abstract][Full Text] [Related]
28. [Early detection of prostate cancer by PSA testing: the results of a qualitative study on barriers caused by physicians in Austria implementing informed decision making].
Malli G
Gesundheitswesen; 2013 Jan; 75(1):22-8. PubMed ID: 22836936
[TBL] [Abstract][Full Text] [Related]
29. Prostate cancer screening practices and beliefs.
Voss JD; Schectman JM
J Gen Intern Med; 2001 Dec; 16(12):831-7. PubMed ID: 11903762
[TBL] [Abstract][Full Text] [Related]
30. Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States.
Nguyen DD; Trinh QD; Cole AP; Kilbridge KL; Mahal BA; Hayn M; Hansen M; Han PKJ; Sammon JD
Cancer; 2021 Jan; 127(2):249-256. PubMed ID: 33165954
[TBL] [Abstract][Full Text] [Related]
31. Primary care physicians' reported use of pre-screening discussions for prostate cancer screening: a cross-sectional survey.
Linder SK; Hawley ST; Cooper CP; Scholl LE; Jibaja-Weiss M; Volk RJ
BMC Fam Pract; 2009 Mar; 10():19. PubMed ID: 19296843
[TBL] [Abstract][Full Text] [Related]
32. How Much Information Do Icelandic Men Receive on Pros and Cons of Prostate-Specific Antigen Testing Prior to Undergoing Testing?
Eiriksdottir VK; Baldursdottir B; Fridriksson JO; Valdimarsdottir HB
Am J Mens Health; 2022; 16(3):15579883221097805. PubMed ID: 35608380
[TBL] [Abstract][Full Text] [Related]
33. Testing and referral patterns in the years surrounding the US Preventive Services Task Force recommendation against prostate-specific antigen screening.
Hutchinson R; Akhtar A; Haridas J; Bhat D; Roehrborn C; Lotan Y
Cancer; 2016 Dec; 122(24):3785-3793. PubMed ID: 27658175
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer screening decision-making in three states: 2013 behavioral risk factor surveillance system analysis.
Li J; Hall IJ; Zhao G
Cancer Causes Control; 2017 Mar; 28(3):235-240. PubMed ID: 28210882
[TBL] [Abstract][Full Text] [Related]
35. Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study.
Pickles K; Carter SM; Rychetnik L
BMJ Open; 2015 Mar; 5(3):e006367. PubMed ID: 25783420
[TBL] [Abstract][Full Text] [Related]
36. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
[TBL] [Abstract][Full Text] [Related]
37. Shared decision making and prostate-specific antigen based prostate cancer screening following the 2018 update of USPSTF screening guideline.
Jiang C; Fedewa SA; Wen Y; Jemal A; Han X
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):77-80. PubMed ID: 32296126
[TBL] [Abstract][Full Text] [Related]
38. [Practice of early detection of prostate cancer : Descriptive survey in preparation for the PSAInForm study].
Simbrich A; Semjonow A; Donner-Banzhoff N; Hense HW
Urologe A; 2018 Jun; 57(6):702-708. PubMed ID: 29671079
[TBL] [Abstract][Full Text] [Related]
39. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
[TBL] [Abstract][Full Text] [Related]
40. Primary Care Physicians Beliefs about Prostate-Specific Antigen Evidence Uncertainty, Screening Efficacy, and Test Use.
Ross LE; Hall IJ; Howard DL; Rim SH; Richardson LC
J Natl Med Assoc; 2018 Oct; 110(5):491-500. PubMed ID: 30129508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]